The current work proposes a novel determination method for enantiomeric excess (ee) in (mono- and di-) amines using a molecular self-assembly. The pyridine-attached binaphtyl derivative ((R)-1) exhibites fluorescence responses based on imine formation between the aldehyde group of (R)-1 and target chiral amines (i.e. cyclohexane diamine (CHDA), 2-amino-1,2-diphenylethanol (ADPE), 1,2-Diphenylethylenediamine (DPDA), 1-amino-2-indanol (AID), and leucinol) in the presence of zinc(II) ion (Zn2+). Because of the mult-optical responses which are derived from the variation of chiral complexes, the pattern recognition-based discrimination (i.e. linear discriminant analysis (LDA)) has been achieved for five types of enantiomeric pairs of amines. Possessing such discrimiantion capability in combination with the data processing (LDA and artificial neural network) allows accurate determination (prediction error < 1.8%) of %ee of individual targets such as CHDA which is one of the main components of drugs. The simple molecular self-assembled system enabled simultaneous multi-chiral discrimination and the %ee determination of unknown samples.
19 October 2018 in Journal of Materials Chemistry B
In this study, we investigated a new class of artificial enzymes composed of Mn-porphyrin, imidazole, and cucurbit[10]uril (CB[10]) toward therapeutic antioxidants. Structural characterization by means of NMR indicated that the inclusion mode of metalloporphyrin in CB[10] was sensitive to the chemical structure of metalloporphyrin and that the structure of the artificial enzyme had a similarly to that of native heme catalase. Kinetic analysis for catalytic antioxidative activities demonstrated that the artificial enzyme exhibited highly efficient activity for H2O2 disproportionation (catalase activity) in water. The activity was classified as top-performing among the water-soluble artificial catalases. The artificial enzyme was constructed by simply mixing the components in water. We consider that this is a great advantage over previously reported artificial catalases, which require a multi-step synthesis or that lack water solubility. The pro-oxidative peroxidase activity was remarkably suppressed due to inclusion in CB[10]. Furthermore, a preliminary in vitro study suggested that the artificial enzyme catalytically eliminated reactive oxygen species, including H2O2, in human cell lines. It was presumed that CB[10] contributed to the bioavailability of the artificial enzyme. Overall, the artificial enzyme was shown to have high potential as a therapeutic antioxidant. We consider that the results in this study could lead to a new conceptual advance toward therapeutic antioxidants that could simultaneously improve the catalytic and biological properties of Mn-porphyrins.
Catalytic antioxidants have attracted intensive attention for the therapy of diseases associated with reactive oxygen species (ROS). Based on the structure of the active site of native antioxidative enzymes, numerous catalytic antioxidants have been designed and synthesized for certain catalytic antioxidative activities. Catalytic antioxidants have been shown to exhibit superoxide dismutase activity, peroxynitrite (ONOO−)-reduction activity, catalase activity, and glutathione peroxidase activity. Although significant antioxidative activities have been achieved in oxidative stress models in vitro and in vivo, their practical application in humans remains highly challenging, and to date, only a few catalytic antioxidants have reached the stage of clinical testing. Understanding the current status of catalytic antioxidants and related issues would provide inspiration to the development of new methods for the therapy of diseases associated with ROS. Therefore, in this review, we focus on selected studies performed on catalytic antioxidants and their antioxidative activities in vitro and in vivo, and their current status with regard to clinical tests. Also, we mention the future prospects based on the catalytic antioxidative studies reported recently.